VAR - Varian Medical Systems, Inc.

NYSE - NYSE Delayed Price. Currency in USD
106.12
-2.12 (-1.96%)
At close: 4:03PM EDT

106.12 0.00 (0.00%)
After hours: 5:10PM EDT

Stock chart is not supported by your current browser
Previous Close108.24
Open108.32
Bid104.50 x 800
Ask113.80 x 800
Day's Range105.78 - 109.07
52 Week Range101.42 - 142.50
Volume906,004
Avg. Volume593,582
Market Cap9.636B
Beta (3Y Monthly)0.81
PE Ratio (TTM)28.88
EPS (TTM)3.67
Earnings DateOct 21, 2019 - Oct 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date1998-12-02
1y Target Est140.71
Trade prices are not sourced from all markets
  • Varian Medical Systems, Inc. (NYSE:VAR) Is Employing Capital Very Effectively
    Simply Wall St.

    Varian Medical Systems, Inc. (NYSE:VAR) Is Employing Capital Very Effectively

    Today we are going to look at Varian Medical Systems, Inc. (NYSE:VAR) to see whether it might be an attractive...

  • PR Newswire

    Dr. Phil Febbo Named to Varian Board of Directors

    PALO ALTO, Calif., Aug. 21, 2019 /PRNewswire/ -- Varian (VAR) today announced that Phil Febbo, MD, chief medical officer (CMO) at Illumina has been appointed to the Varian Board of Directors, effective August 16, 2019. "We are proud to have Phil Febbo join the Varian Board," said R. Andrew Eckert, chairman of Varian's Board of Directors. "Phil has a strong background in both clinical and research work, as well as company strategy.

  • PR Newswire

    Varian Completes Purchase of Embolic Bead Asset

    PALO ALTO, Calif. , Aug. 21, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has successfully completed its asset purchase of the Boston Scientific portfolio of drug-loadable microsphere and ...

  • Here's Why You Should Hold Varian Medical (VAR) Stock Now
    Zacks

    Here's Why You Should Hold Varian Medical (VAR) Stock Now

    Varian (VAR) raises the revenue guidance for fiscal 2019.

  • PR Newswire

    Varian to Hold Investor Day in New York City

    PALO ALTO, Calif., Aug. 19, 2019 /PRNewswire/ -- Varian (VAR) today announced that its executive management team will be hosting an Investor Day on Friday, November 15, 2019 at The Plaza Hotel, Fifth Avenue at Central Park South, New York, NY 10019, from 8:00am to 1:00pm ET. Varian will outline its growth initiatives in radiation oncology, interventional oncology, and more broadly across cancer care driven by its 'Intelligent Cancer Care' approach, the next wave of progress in oncology that harnesses advanced technologies like artificial intelligence, machine learning, and data analytics to ensure coordination and connectivity at every point of care.  'Intelligent Cancer Care' puts the patient and provider at the center of our thinking to help realize our vision of a world without fear of cancer.

  • PR Newswire

    Varian to Host Investor Meeting at ASTRO in Chicago

    PALO ALTO, Calif., Aug. 8, 2019 /PRNewswire/ -- Varian (VAR) today announced that its executive staff will be meeting with analysts and investors at the American Society for Radiation Oncology (ASTRO) Annual Meeting in Chicago on Monday, September 16, 2019 at 2:00 p.m. Central Time. To attend Varian's ASTRO investor meeting, please RSVP to Katie Glenn at katie.glenn@varian.com by August 23, 2019. For automatic e-mail alerts regarding Varian news and events, investors can subscribe on the company website: http://investors.varian.com/emailalerts.

  • Looking At Varian Medical Systems, Inc. (NYSE:VAR) From All Angles
    Simply Wall St.

    Looking At Varian Medical Systems, Inc. (NYSE:VAR) From All Angles

    I've been keeping an eye on Varian Medical Systems, Inc. (NYSE:VAR) because I'm attracted to its fundamentals. Looking...

  • PR Newswire

    Varian Announces Immaterial Impact of Newly Proposed Tariffs

    PALO ALTO, Calif., Aug. 5, 2019 /PRNewswire/ -- Varian (VAR) today announced that the newly proposed tariffs by the U.S. on the remaining $300 billion of Chinese imports should have no material impact to the company. Last Thursday, the U.S. announced plans to impose a 10 percent tax on $300 billion in Chinese imports beginning September 1, 2019.  Varian estimates these newly proposed tariffs should have an immaterial financial impact. At Varian, we envision a world without fear of cancer.  For more than 70 years, we have developed, built and delivered innovative cancer care technologies and solutions for our clinical partners around the globe to help them treat millions of patients each year.  With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.  Our 9,200 employees across 70 countries keep the patient and our clinical partners at the center of our thinking as we power new victories in cancer care.  Because, for cancer patients everywhere, their fight is our fight.  For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

  • PR Newswire

    Three Radiotherapy Centers in Serbia Standardize on Varian Solution for Cancer Treatment Planning

    PALO ALTO, Calif. , July 29, 2019 /PRNewswire/ -- Following a public competitive review process, Varian (NYSE: VAR) was selected to supply its Eclipse ™ treatment planning software and ARIA ® oncology ...

  • Thomson Reuters StreetEvents

    Edited Transcript of VAR earnings conference call or presentation 24-Jul-19 8:30pm GMT

    Q3 2019 Varian Medical Systems Inc Earnings Call

  • Why Varian Medical Systems Is Tanking Today
    Motley Fool

    Why Varian Medical Systems Is Tanking Today

    Shares slump after the radiation-therapy company reported mixed quarterly results.

  • Stock Market News for Jul 25, 2019
    Zacks

    Stock Market News for Jul 25, 2019

    The broader S&P 500 and tech-heavy Nasdaq reached record highs on Wednesday, riding a rally in semiconductor stocks.

  • Varian (VAR) Earnings and Revenues Surpass Estimates in Q3
    Zacks

    Varian (VAR) Earnings and Revenues Surpass Estimates in Q3

    Varian (VAR) expects revenue growth in the range of 9-10% for fiscal 2019.

  • PR Newswire

    Karolinska University Hospital Solna Delivers HDR Brachytherapy Cancer Treatments with Varian Bravos Afterloader System

    PALO ALTO, Calif. and STOCKHOLM, July 25, 2019 /PRNewswire/ -- Varian (VAR) announced that the Karolinska University Hospital Solna in Sweden is the first hospital in Scandinavia to deliver High Dose Rate (HDR) brachytherapy treatments using the new Bravos™ afterloader system. Bravos is an advanced integrated system designed to improve the patient and clinic experience by simplifying brachytherapy treatments and provide greater workflow efficiency. HDR brachytherapy involves delivering radiotherapy by temporarily placing a small radioactive source directly into the tumor or other targeted area.

  • Varian Medical Systems Inc (VAR) Q3 2019 Earnings Call Transcript
    Motley Fool

    Varian Medical Systems Inc (VAR) Q3 2019 Earnings Call Transcript

    VAR earnings call for the period ending June 28, 2019.

  • PR Newswire

    Varian Reports Results for Third Quarter of Fiscal Year 2019

    PALO ALTO, Calif. , July 24, 2019 /PRNewswire/ -- Third Quarter 2019 Summary Oncology Systems gross orders grew 2% in dollars, or 4% in constant currency; Trailing twelve months gross orders grew 11% in ...

  • Varian Medical Systems (NYSE:VAR) Shareholders Have Enjoyed A 61% Share Price Gain
    Simply Wall St.

    Varian Medical Systems (NYSE:VAR) Shareholders Have Enjoyed A 61% Share Price Gain

    Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...

  • What's in Store for Varian Medical (VAR) in Q3 Earnings?
    Zacks

    What's in Store for Varian Medical (VAR) in Q3 Earnings?

    Probable revenue growth in APAC and EMEA regions and higher Oncology revenues are likely to aid Varian Medical (VAR) in Q3 earnings. However, contraction in margins might be a dampener.

  • Will USTR's 25% Tariff Exemption Spell Relief for MedTech?
    Zacks

    Will USTR's 25% Tariff Exemption Spell Relief for MedTech?

    In the wake of the U.S. tariff and Chinese retaliation, the MedTech industry players (with production houses in China) are facing huge bottom line pressure.

  • Varian Medical Systems (VAR) Earnings Expected to Grow: Should You Buy?
    Zacks

    Varian Medical Systems (VAR) Earnings Expected to Grow: Should You Buy?

    Varian (VAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • US-India Trade Tensions Rise: 3 Stocks in the Line of Fire
    Zacks

    US-India Trade Tensions Rise: 3 Stocks in the Line of Fire

    As India moves toward self-sufficiency, U.S. MedTech bigwigs fret over possible losses.

  • GuruFocus.com

    Varian Medical Systems Inc (VAR) SVP, Finance & CFO Gary E Jr Bischoping Sold $7. ...

    SVP, Finance & CFO of Varian Medical Systems Inc (30-Year Financial, Insider Trades) Gary E Jr Bischoping (insider trades) sold 56,232 shares of VAR on 07/11/2019 at an average price of $132.56 a share. Continue reading...

  • PR Newswire

    Varian to Showcase Cancer Care Systems and Software at AAPM 2019

    PALO ALTO, Calif. , July 11, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced it will be showcasing systems and software from its cancer care portfolio, including the IDENTIFY ™ Guidance System, ...

  • Stock Market News For Jul 10, 2019
    Zacks

    Stock Market News For Jul 10, 2019

    Markets closed mostly higher on Tuesday as investors awaited Powell's testimony.

  • Varian (VAR) Installs ProBeam Compact in Thailand's Hospital
    Zacks

    Varian (VAR) Installs ProBeam Compact in Thailand's Hospital

    Varian (VAR) gains from a slew of recent developments in its Proton Therapy platform.